浮针治疗肝郁痰凝型单纯性乳腺增生症
Floating Needle Therapy for Simple Hyperplasia of Mammary Glands of Liver Depression and Phlegm Coagulation Type
DOI: 10.12677/acm.2025.15103006, PDF,   
作者: 李 航:黑龙江中医药大学研究生院,黑龙江 哈尔滨;刘 鹏*:黑龙江中医药大学附属第一医院针灸六科,黑龙江 哈尔滨
关键词: 浮针疗法乳腺增生乳房疼痛Floating Needle Therapy Mammary Hyperplasia Breast Pain
摘要: 目的:探讨浮针治疗单纯性乳腺增生症的临床疗效。方法:将80例单纯性乳腺增生症肝郁痰凝型、外上象限疼痛的患者随机分为研究组和对照组,每组各40例。研究组给予浮针疗法(扫散 + 再灌注)治疗;对照组给予普通针刺疗法治疗。从月经来潮七天前开始进行治疗,直至月经来潮,治疗为每日1次,共治疗4个月经周期。观察两组患者治疗前后VAS评分、乳腺疼痛评分、医院焦虑抑郁量表(HADS)评分的变化情况。结果:研究组总有效率为96.67%,对照组总有效率为83.33% (P < 0.05),研究组优于对照组;2组患者治疗后VAS评分、乳腺疼痛评分、医院焦虑抑郁量表(HADS)评分均降低(P < 0.05),且研究组优于对照组。结论:浮针治疗在缓解单纯性乳腺增生的临床症状上疗效显著,优于普通针刺疗法。
Abstract: Objective: To investigate the clinical effect of floating acupuncture in the treatment of simple mammary hyperplasia. Methods: 80 patients with simple mammary hyperplasia with liver-depression spittoon and pain in the upper quadrant were randomly divided into study group and control group, 40 cases in each group. The study group was given floating needle therapy (scavenging + reperfusion). The control group was treated with ordinary acupuncture therapy. From seven days before the onset of menstruation to the onset of menstruation, the treatment is once a day, a total of 4 menstrual cycles. VAS score, breast pain score and hospital Anxiety and Depression Scale (HADS) score were observed before and after treatment in two groups. Results: The total effective rate of the study group was 96.67%, and that of the control group was 83.33% (P < 0.05). VAS score, breast pain score and hospital Anxiety and Depression Scale (HADS) score of 2 groups were decreased after treatment (P < 0.05), and the study group was better than the control group. Conclusion: Floating needle therapy is effective in relieving the clinical symptoms of simple mammary hyperplasia, which is superior to ordinary acupuncture therapy.
文章引用:李航, 刘鹏. 浮针治疗肝郁痰凝型单纯性乳腺增生症[J]. 临床医学进展, 2025, 15(10): 2241-2246. https://doi.org/10.12677/acm.2025.15103006

参考文献

[1] 朱锡琪, 李玉珠. 乳腺外科学[M]. 上海: 上海医科大学出版社, 1995: 99-108.
[2] 孙朝渭, 刘鑫程, 董禹何, 等. 乳腺增生症的中西医认识及分泌型卷曲相关蛋白1(SFRP1)对发病机制的作用[J]. 实用中医内科杂志, 2024, 38(8): 65-68.
[3] 陈显春, 蒋成刚, 陈庆秋, 等. 675例乳腺增生女性患者的焦虑、抑郁情绪及其与生活事件和人格的关系研究[J]. 第三军医大学学报, 2014, 36(2): 174-176.
[4] 毛树文, 季远. 王国才推拿治疗乳腺增生症经验浅析[J]. 上海中医药杂志, 2010, 44(7): 1-2.
[5] 陶嘉磊, 符仲华, 张宏如. 浮针疗法作用机制浅析[J]. 时珍国医国药, 2014, 25(12): 3006-3008.
[6] 白秀萍, 谢素萍, 江莉. 乳腺增生与乳腺癌[M]. 北京: 中国医药科技出版社, 2016.
[7] 郑筱萸. 中药新药临床研究指导原则(试行) [M]. 北京: 中国医药科技出版社, 2002.
[8] Woodforde, J.M. and Merskey, H. (1972) Some Relationships between Subjective Measures of Pain. Journal of Psychosomatic Research, 16, 173-178. [Google Scholar] [CrossRef] [PubMed]
[9] Jensen, M.P., Chen, C. and Brugger, A.M. (2003) Interpretation of Visual Analog Scale Ratings and Change Scores: A Reanalysis of Two Clinical Trials of Postoperative Pain. The Journal of Pain, 4, 407-414. [Google Scholar] [CrossRef
[10] 孙振晓, 刘化学, 焦林瑛, 等. 医院焦虑抑郁量表的信度及效度研究[J]. 中华临床医师杂志(电子版), 2017, 11(2): 198-201.
[11] 孙咏冰, 黄辉煌, 宋兵, 等. 新型冠状病毒肺炎流行期间某医院HIV/AIDS患者焦虑抑郁及相关因素的研究[J]. 中国艾滋病性病, 2022, 28(9): 1045-1049.
[12] 熊禄娅, 李雪真, 郭智涛. 刺血疗法联合消散方外敷治疗乳腺增生的疗效观察[J]. 广州中医药大学学报, 2023, 40(4): 893-898.
[13] 艾比拜姆·喀迪尔, 米哈古丽·阿布力孜. 浅谈乳腺增生症的发病机制及研究进展[J]. 世界最新医学信息文摘, 2019, 19(62): 34.
[14] 林淑雯, 李天禹. 乳腺增生症中西医发病机制及治疗的认识[J]. 齐齐哈尔医学院学报, 2020, 41(6): 742-744.
[15] 丘丽华, 刘秋织, 熊茜. 胸肩脊同调治疗乳腺增生症100例临床疗效观察[J]. 按摩与康复医学, 2022, 13(14): 9-11.
[16] 张丽华, 刘悦. 浮针治疗乳腺增生症乳房疼痛30例临床研究[J]. 江苏中医药, 2018, 50(10): 46-48.